Adrenal venous sampling in patients with ACTH-independent hypercortisolism.


Journal

Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444

Informations de publication

Date de publication:
11 2019
Historique:
received: 15 05 2019
accepted: 26 07 2019
pubmed: 24 8 2019
medline: 28 5 2020
entrez: 24 8 2019
Statut: ppublish

Résumé

To study the usefulness of adrenal venous sampling (AVS) in distinguishing unilateral from bilateral cortisol production in patients with ACTH-independent hypercortisolism and bilateral adrenal lesions, or morphologically normal adrenal glands. A retrospective analysis of ten consecutive patients with ACTH-independent hypercortisolism who underwent AVS at our institution between 2009 and 2017. Unilateral dominant cortisol production was defined as a side-to-side cortisol/aldosterone lateralization ratio >2. Four of ten patients had overt Cushing's syndrome. Of these, two had bilateral adrenal lesions on computed tomography and two had normal adrenal glands. One of the two patients with bilateral adrenal lesions had, based on the AVS, a unilateral dominant cortisol production. Following unilateral adrenalectomy the patient developed adrenal insufficiency. The other three patients were considered to have bilateral cortisol production and underwent bilateral adrenalectomy. Six patients had a mild autonomous cortisol secretion and bilateral adrenal lesions. Based on AVS, one patient was considered to have unilateral dominant cortisol production, underwent unilateral adrenalectomy and developed transient adrenal insufficiency postoperatively. AVS may contribute to appropriate treatment in patients with ACTH-independent hypercortisolism and bilateral adrenal lesions. In our series, AVS was helpful in the decision-making of two out of ten patients, avoiding chronic treatment with steroidogenesis inhibitors, or inappropriate bilateral adrenalectomy.

Identifiants

pubmed: 31440949
doi: 10.1007/s12020-019-02038-0
pii: 10.1007/s12020-019-02038-0
pmc: PMC6838037
doi:

Substances chimiques

Dehydroepiandrosterone Sulfate 57B09Q7FJR
Adrenocorticotropic Hormone 9002-60-2
Hydrocortisone WI4X0X7BPJ
Norepinephrine X4W3ENH1CV
Epinephrine YKH834O4BH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

338-348

Références

J Clin Endocrinol Metab. 2010 Mar;95(3):1328-32
pubmed: 20061413
Endocrinol Metab Clin North Am. 2005 Jun;34(2):441-58, x
pubmed: 15850852
Endocrinol Metab (Seoul). 2013 Jun;28(2):133-7
pubmed: 24396667
Endocrine. 2013 Feb;43(1):219-24
pubmed: 22971951
J Clin Endocrinol Metab. 1994 Dec;79(6):1532-9
pubmed: 7989452
Intern Med. 2012;51(4):395-400
pubmed: 22333376
Tokai J Exp Clin Med. 2015 Dec 20;40(4):149-56
pubmed: 26662665
J Clin Endocrinol Metab. 2015 Dec;100(12):4417-24
pubmed: 26451908
Int J Surg. 2012;10(9):555-9
pubmed: 22959968
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4553-4560
pubmed: 30137397
J Clin Endocrinol Metab. 2015 Nov;100(11):4332-8
pubmed: 26390100
Surgery. 2004 Dec;136(6):1227-35
pubmed: 15657580
Endocr Pract. 2013 May-Jun;19(3):515-21
pubmed: 23425643
Clin Endocrinol (Oxf). 2011 Apr;74(4):438-44
pubmed: 21175735
J Clin Endocrinol Metab. 2016 May;101(5):1889-916
pubmed: 26934393
Eur J Pediatr Surg. 2010 Jul;20(4):273-5
pubmed: 20099223
Asian J Surg. 2007 Apr;30(2):154-7
pubmed: 17475590
Colomb Med (Cali). 2015 Jun 30;46(2):84-7
pubmed: 26309345
Am J Hypertens. 2002 May;15(5):459-64
pubmed: 12022249
J Clin Endocrinol Metab. 2011 May;96(5):1223-36
pubmed: 21367932
World J Surg. 2008 May;32(5):882-9
pubmed: 18214589
Endocr Pract. 2012 Nov-Dec;18(6):e153-7
pubmed: 22982799
J Nucl Med. 1990 Apr;31(4):526-34
pubmed: 2324830
J Pediatr Endocrinol Metab. 2011;24(3-4):197-202
pubmed: 21648292
Hypertension. 2013 Dec;62(6):1152-7
pubmed: 24082051
World J Surg. 2008 May;32(5):856-62
pubmed: 18074172
J Clin Endocrinol Metab. 1998 Jan;83(1):55-62
pubmed: 9435416
Endocrinol Diabetes Metab Case Rep. 2016;2016:150118
pubmed: 27252858
Lancet. 2006 May 13;367(9522):1605-17
pubmed: 16698415
Diagn Interv Radiol. 2018 Mar-Apr;24(2):89-93
pubmed: 29467114
Semin Nucl Med. 2006 Jul;36(3):212-27
pubmed: 16762612
Lancet. 2015 Aug 29;386(9996):913-27
pubmed: 26004339

Auteurs

Eleni Papakokkinou (E)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. eleni.papakokkinou@vgregion.se.
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden. eleni.papakokkinou@vgregion.se.

Hugo Jakobsson (H)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Augustinas Sakinis (A)

Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Andreas Muth (A)

Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

Bo Wängberg (B)

Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

Olof Ehn (O)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Gudmundur Johannsson (G)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Oskar Ragnarsson (O)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH